# Mesenchymal Stromal Cells for Ischemic Stroke

> **NCT01922908** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Sean Savitz**

## Conditions studied

- Ischemic Stroke

## Interventions

- **BIOLOGICAL:** MSC Infusion
- **BIOLOGICAL:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01922908
- **Lead sponsor:** Sean Savitz
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-12
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Plan to change the trial design
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01922908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01922908, "Mesenchymal Stromal Cells for Ischemic Stroke". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01922908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*